Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02235467
Other study ID # U1111-1157-8984
Secondary ID 2012/51584-0
Status Completed
Phase Phase 4
First received September 5, 2014
Last updated March 31, 2015
Start date February 2014
Est. completion date December 2014

Study information

Verified date March 2015
Source Federal University of São Paulo
Contact n/a
Is FDA regulated No
Health authority Brazil: Ministry of Health
Study type Interventional

Clinical Trial Summary

This is a Brazilian multisite study to test the efficacy of an Applied Behavior Analysis (ABA) parent training using video modeling to teach parents of children with Autism techniques to apply to their children in order to improve eye contact and joint attention behaviors.

Our hypothesis is that children with Autism whose parents will be trained by videomodeling will have better eye contact and joint attention behaviors compared to children with Autism whose parents will not be trained.


Description:

Applied Behavior Analysis (ABA) is an intervention with proven efficacy in treating impairments on social functioning and daily-life activities of individuals with Autism Spectrum Disorder (ASD). In Brazil we have a limited number of qualified professionals and an increasing demand of families non-served in the public health system.

Our main objective is to standardize and test the efficacy of a model for parent training using video modeling for teaching eye contact and joint attention behaviors in children with ASD. These two behaviors are essential to develop adequate social interaction, the core impaired domain in ASD. It is a multisite study to be carried out at the Universidade Federal de São Paulo, Universidade de São Paulo and Universidade Presbiteriana Mackenzie. The sample will be composed of 70 children divided in control and intervention groups that will be randomly chosen. The intervention should be carried out in 21 weeks.


Recruitment information / eligibility

Status Completed
Enrollment 67
Est. completion date December 2014
Est. primary completion date December 2014
Accepts healthy volunteers No
Gender Both
Age group 3 Years to 7 Years
Eligibility Inclusion Criteria:

- Clinical Diagnosis of Autism Spectrum Disorders

- Diagnosis of Autism Spectrum Disorders by means of ADI

- IQ equal or lower than 70 by means of SON

- Main caregiver's level of education > primary education

Exclusion Criteria:

- IQ lower than 50 by means of SON

- Child who is receiving ABA therapy at least 10 hours per week

- Main caregiver diagnosed with Autism Spectrum Disorders

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Behavioral:
ABA parent training
A parent training based on Applied Behavior Analysis that is going to be delivered by video modeling in 21 weeks

Locations

Country Name City State
Brazil Federal University of São Paulo Department of Psychiatry São Paulo

Sponsors (3)

Lead Sponsor Collaborator
Federal University of São Paulo Mackenzie Presbiterian University, São Paulo, Brazil, University of Sao Paulo

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Other Change from baseline in KAP at 21 weeks Improvement on the knowledge, attitude and practice (KAP) questionnaire baseline assessment to 21 weeks No
Other Change from baseline in Hamilton scalels and at 21 weeks Improvement on the Hamilton Depression and Anxiety scales of the caregiver baseline assessment to 21 weeks No
Primary Acquisition from baseline of new behaviors at 8 weeks acquisition of new behaviors (eye contact and joint attention) checked through taped interactions between child and a family member baseline assessment to 8 weeks of therapy No
Primary Acquisition from baseline of new behaviors at 16 weeks acquisition of new behaviors (eye contact and joint attention) checked through taped interactions between child and a family member baseline assessment to 16 weeks No
Primary Acquisition from baseline of new behaviors at 21 weeks acquisition of new behaviors (eye contact and joint attention) checked through taped interactions between child and a family member baseline to 21 weeks No
Secondary Change from baseline in Eye-tracking at 21 weeks Latency, duration, and sequence of visual fixations measured with eye-tracking baseline assessment to 21 weeks No
Secondary Change from baseline in Vineland Scale at 21 weeks Adaptative behavior using Vineland Scale baseline assessment to 21 weeks No
Secondary Change from baseline in SON-R 2½-7 at 21 weeks Improve on SON-R 2½-7 that is an intelligence coefficient test developed for deaf people baseline assessment to 21 weeks No
Secondary Change from baseline in Zaritt Burden Interview at 21 weeks The Zaritt Burden Interview measures the caregiver burden of taking care of the relative with psychiatric disorder baseline assessment to 21 weeks No
Secondary Change from baseline in OERA at 21 weeks OERA (Observação Estruturada para Rastreamento de Autismo) is a taped structured observation to screen Autism that was developed by Brazilian researchers. baseline assessment to 21 weeks No
See also
  Status Clinical Trial Phase
Active, not recruiting NCT02625116 - ELENA Cohort: A Long-term Longitudinal Study in a Pediatric Sample With Autism Spectrum Disorders
Not yet recruiting NCT06381856 - Improving Participation of Autistic Children and Adolescents in the Habilitation Process
Recruiting NCT02280746 - Gluten for Autism Spectrum Disorders N/A
Completed NCT01945957 - Brain Imaging of Intranasal Oxytocin Treatment in Autism Phase 1
Completed NCT01661855 - A Pilot Study of Riluzole Versus Placebo in the Treatment of Children and Adolescents With ASD Phase 2
Completed NCT01691066 - Pivotal Response Treatment for Infants At-Risk for Autism Spectrum Disorder N/A
Completed NCT01780090 - Handheld Technology for Speech Development in Students With Autism N/A
Completed NCT01592747 - Withdrawal Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified Previously Treated With Memantine Phase 2
Completed NCT01694667 - Omega-3 Fatty Acids for Hyperactivity Treatment in Autism Spectrum Disorder Phase 2
Active, not recruiting NCT01417026 - Intranasal Oxytocin and Learning in Autism Phase 2
Enrolling by invitation NCT01364818 - Brain Connectivity in Neurodevelopmental Disorders in Response to Treatment N/A
Completed NCT01695200 - Omega-3 Fatty Acids in Autism Spectrum Disorders Phase 4
Completed NCT02300597 - Internet-based Support for Young People With ADHD and Autism - a Controlled Study N/A
Not yet recruiting NCT00695812 - The Development of Younger Siblings of Children With Autism Now at 10 Years of Age N/A
Completed NCT01675414 - Understanding Gastrointestinal Conditions in Children With Autism Spectrum Disorder (ASD) N/A
Recruiting NCT05910502 - Project AFECT (Autism Family Empowerment Coaching and Training Program) N/A
Completed NCT02081027 - Pilot Study of Riluzole for Drug-Refractory Irritability in Autism Spectrum Disorders Early Phase 1
Completed NCT02797379 - The Development of a Psychoeducational Tool to Manage Anxiety in People With Autism Spectrum Disorders N/A
Terminated NCT01730079 - Near Infrared Spectroscopy in Children With Autism and ADHD
Completed NCT01603225 - Transcranial Direct Current Stimulation and Autism